Information Library
News Items
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL
August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.
-
NOBEL LAUREATE JOINS QUINTILES SCIENTIFIC ADVISORY BOARD
August 11, 2010 – Quintiles' announces the addition of Aaron Ciechanover, M.D., D.Sc., recipient of the Nobel Prize in Chemistry in 2004, to its Translational Research and Development Scientific Advisory Board.
-
QUINTILES EXTENDS DATA MANAGEMENT EXPERTISE, CAPABILITIES TO CHINA
August 9, 2010 - Quintiles today announced the expansion of its data management services into Shanghai, China, strengthening the company’s capability to serve customers in that country and the Asia-Pacific region.
-
QUINTILES NAMES NEW CHIEF FINANCIAL OFFICER
August 2, 2010 – Quintiles today announced the appointment of Kevin K. Gordon to serve as Chief Financial Officer (CFO) effective immediately. In this role, he will have day to day responsibility for the financial management of the company.
-
QUINTILES ANNOUNCES NEW EUROPEAN HEADQUARTERS
July 29, 2010 - Quintiles, announced that it is re-locating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading overlooking the M4 motorway.
-
QUINTILES NAMED ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION OF THE YEAR BY FROST & SULLIVAN
July 9, 2010 - Quintiles, has been named the 2010 Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan.
-
QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE
July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program - an initiative focused on accelerating the development of new and more effective medicines.
-
THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS
June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.
-
THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT
June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.
-
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
